30th Annual Recent Advances in Clinical Nuclear Cardiology and Cardiac CT: Featuring Case Review with the Experts
Co-sponsored
by:
 
Offered in Cooperation with:
Program Directors: Daniel S. Berman, MD, FACC; Guido Germano, PhD, MBA, FACC; Jamshid Maddahi, MD, FACC
May
8 - 10, 2008
JW Marriott
Washington DC
PROGRAM PRESENTATIONS
Please note that pdfs are not listed for all program presentations as some faculty were unable to provide their full slide presentations to ACCF. Please refer to your printed syllabus for the key slides and/or abstracts that were released at the program.
Thursday, May 8
Myocardial Perfusion/Function SPECT and PET
Dr. Berman, Presiding
8:15 a.m. Physiologic Principles and Current Protocols for Myocardial Perfusion SPECT and PET
Dr. Maddahi
8:45 a.m. Workshop I: PET vs. SPECT for Rest/Stress Myocardial Perfusion Studies: Case Illustrations
Dr. Bateman
9:15 a.m. Adenosine, Dipyridamole and Dobutamine SPECT/PET MPI: Practical Considerations
Dr. Hayes
9:45 a.m. Office-based Nuclear Cardiology: Optimizing Protocols, Coding and Reimbursement
Dr. Bateman
10:45 a.m. Workshop II: Interpretation and Reporting of Gated Myocardial Perfusion/Function SPECT: A Systematic Approach
Dr. Berman - Updated Presentation
11:30 a.m. Physics and Technical Aspects of Myocardial Perfusion SPECT and PET: The Essentials
Dr. Germano
12:15 p.m. Lunch Presentation: Update on Advocacy and Imaging
Ms. Greenan and Ms. Kovar
1:15 p.m. Workshop III: Integrating Visual and Quantitative Analysis: Case Illustrations
Dr. Hayes
2:00 p.m. Workshop IV: Pitfalls of Gated SPECT: Recognizing and Working with Artifacts
Dr. Ziffer
3:15 p.m. Workshop V: Reviewing the Raw Data: An Integral Part of SPECT Interpretation
Dr. Hayes
4:00 p.m. Workshop VI: Quantitative Analysis of Gated Myocardial Perfusion SPECT
Dr. Germano
Friday, May 9
Risk Stratification and Patient Management Using SPECT, PET and CMR
Dr. Berman, Presiding
8:00 a.m. Myocardial Viability: Integrating the Use of Nuclear, Echo and CMR Methods
Dr. Bonow
8:40 a.m. Nuclear Risk Stratification and Guiding Patient Management in Chronic CAD
Dr. Hachamovitch
9:20 a.m. Quantification of Myocardial Perfusion: Recent Advances
Dr. Slomka
10:45 a.m. Workshop VII: Pitfalls of PET: Recognizing and Working with Artifacts
Dr. Slomka
11:30 a.m. Which Test for Which Patient: CT Coronary Calcium, Coronary CTA, Nuclear Cardiology and CMR
Dr. Berman Updated Presentation
The Future of Nuclear Cardiology
Dr. Germano, Presiding
1:15 p.m. Hybrid PET/CT or SPECT/CT vs. Sequential Imaging
Dr. Di Carli
2:00 p.m. Workshop VIII: Chest Pain in the ED: Rest/Stress SPECT MPI vs. Coronary CTA
Dr. Ziffer
2:45 p.m. Future of Nuclear Cardiology: Long Awaited Changes
Dr. Berman Updated Presentation
3:30 p.m. Workshop IX: Risk Stratification and Patient Management before Noncardiac Surgery and after CABG and PTCA: Nuclear Cardiology and Cardiac CT
Dr. Maddahi
4:15 p.m. Workshop X: Assessment of Medical Therapy with MPI
Dr. Hachamovitch
Saturday, May 10
Cardiac CT and Its Relationship to Nuclear Cardiology and CMR
Dr. Berman, Presiding
8:00 a.m. Fundamentals of Cardiac CT: Essentials of the Physics and Instrumentation and Protocols
Dr. Weigold
8:20 a.m. Workshop XI: A Systematic Approach to Interpretation of Coronary CTA
Dr. Weigold
9:00 a.m. Diagnostic and Prognostic Value of Coronary CTA
Dr. Min
9:45 a.m. Workshop XII: Pitfalls of Cardiac CT: Recognizing and Working with Artifacts
Dr. Weigold
10:45 a.m. Workshop XIII: MPI vs. Coronary CTA in Patients with Suspected CAD
Dr. Min
11:25 a.m. Workshop XIV: MPI vs. Coronary CTA in Patients with Known CAD
Dr. Hachamovitch
1:15 p.m. Beyond Coronary CTA: The Future of Cardiac CT
Dr. Lardo
2:00 p.m. Workshop XV: Cardiac CT vs. CMR: When is CMR the Test of Choice?
Dr. Raff
2:45 p.m. Applications of Cardiac CT Not Currently Possible with Cardiac PET/SPECT
Dr. Min
3:30 p.m. Coronary CTA: Gaps in the Evidence: What Needs to be Done?
Dr. Raff
|
